Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.2 | 3e-07 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.18 | 8e-07 |
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-06 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-06 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-05 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |